Biotech

All Articles

Kairos goes social along with $6M IPO to fund trials of cancer medicine

.With a trio of biotechs reaching the Nasdaq on Friday, it was actually effortless to overlook a sma...

Vaccine and also Keytruda combination helpful in squamous cell cancer

.Invulnerable checkpoint inhibitors are the superheroes of cancer cells treatment. Medicines like Br...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of notable leadership hirings, firings and al...

Regeneron's Opdualag opponent presents 57% reaction rate

.Regeneron is actually back with long-term consequence for its own LAG-3 inhibitor and PD-1 preventi...

AstraZeneca messages information on internal competitors to AbbVie, Pfizer ADCs

.AstraZeneca has shared an early check out the efficiency of its internal antibody-drug conjugate (A...

iTeos- GSK's TIGIT celebrity reveals significant improvement

.After revealing a phase 3 launch based upon positive midstage results, iTeos and also GSK are lastl...

More collaborative FDA may speed up rare health condition R&ampD: document

.The FDA should be extra open and also collaborative to let loose a surge in approvals of unusual di...

Zenas, MBX, Bicara head to Nasdaq in very hot time for biotech IPOs

.It is actually an abnormally hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bi...

Atea's COVID antiviral neglects to halt hospitalizations in phase 3

.Atea Pharmaceuticals' antiviral has fallen short one more COVID-19 test, however the biotech still ...

Neurocrine's proposal to save schizophrenia prospect neglects

.Neurocrine Biosciences' schizophrenia plan pivot has fallen short. The biotech was incapable to rep...